Shareholders meeting

Date: 5th August, 2026 To, To, The Manager, The Manager, Department of Corporate Services, Listing Department, BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 533573 NSE Symbol: APLLTD Dear Sir/Madam, Sub: Proceedings of the 16th Annual General Meeting held on 5th August, 2026 In accordance with the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith proceedings of the 16th Annual General Meeting of the Company held on 5th August, 2026. We request you to kindly take the same on record. Thanking you, Yours faithfully, For Alembic Pharmaceuticals Limited Manisha Saraf Company Secretary Encl.: A/a. ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123 Proceedings of the 16th Annual General Meeting of Alembic Pharmaceuticals Limited held through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”). Ms. Manisha Saraf, Company Secretary welcomed all Members, Directors, Auditors and other invitees to the 16th Annual General Meeting (“AGM”) of the Members of Alembic Pharmaceuticals Limited (“the Company”) held on Wednesday, the 5th August, 2026 at 4:00 P.M. IST through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”). All the Directors except Mr. Manish Kejriwal and Ms. Geeta Goradia, Independent Directors of the Company attended the Meeting. It was informed that the meeting was held through VC / OAVM without the physical presence of the members at a common venue in accordance with the applicable provisions of the Companies Act, 2013 (“Act”) and Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 (“SEBI Listing Regulations, 2015”) and in compliance with the procedure prescribed vide various circulars issued from Ministry of Corporate Affairs (“MCA”) and Securities and Exchange Board of India (“SEBI”). Ms. Manisha Saraf, Company Secretary confirmed that the quorum was present and declared the meeting in order and open for business. Mr. Chirayu Amin, Chairman requested other Directors to introduce themselves. Mr. Tejas Parikh, Partner of M/s. KKC & Associates LLP, Statutory Auditors and Mr. S. Samdani, Partner of M/s. Samdani Shah & Kabra, Secretarial Auditors and Scrutinizer for this meeting and other company executives joined the meeting through VC from their respective locations. Thereafter, the Company Secretary informed the Members about the relevant points for participation in the meeting and the manner of inspection of the statutory registers electronically as required under the Companies Act, 2013. With the permission of the Chairman and Members, the Notice convening the Meeting, having been circulated to all the members, was taken as read. She further informed the Members that the Company has provided its Members the facility to cast their vote electronically (“remote e-voting”), through the e-voting services provided by NSDL, on all the resolutions set forth in the Notice of AGM and that the Members who have not casted their vote through remote e-voting can cast their vote during the course of the meeting. She further informed that M/s. Samdani Shah & Kabra, Practising Company Secretaries, Vadodara were appointed as Scrutinizer to scrutinize the votes cast through remote e-voting and during the meeting. Thereafter, Mr. Chirayu Amin, Chairman delivered his statement on the affairs of the Company. ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123 Mr. Pranav Amin and Mr. Shaunak Amin, Managing Directors and Mr. G. Krishnan, CFO responded to the questions raised by the Members who had joined the AGM as registered speakers. The following businesses were transacted at the meeting: Ordinary Business: 1. To receive, consider and adopt: a) the Audited Standalone Financial Statements of the Company for the financial year ended 31st March, 2026 together with the Reports of the Board of Directors and Auditors thereon. b) the Audited Consolidated Financial Statements of the Company for the financial year ended 31st March, 2026 together with the Reports of the Auditors thereon. 2. To declare Dividend on equity shares for the financial year 2025-26. 3. To appoint a Director in place of Mr. Pranav Amin (DIN: 00245099), who retires by rotation and being eligible, offers himself for re-appointment. Special Business: 4. Appointment of Mr. Sujit Jaysukh Bhayani (DIN: 01767427) as an Independent Director of the Company: 5. Ratification of Remuneration to the Cost Auditors for the financial year 2026-27: Mr. Chirayu Amin, Chairman thanked all the Directors and Members for joining the meeting through The Members were informed that the voting on NSDL platform would continue for next 15 minutes to enable the members who have not cast their vote yet and who would like to cast their vote and that the results of the voting would be declared on or before 7th August, 2026 and shall be made available on the Notice Board of the Company at its Registered Office, website of the Company, website of NSDL and website of Stock Exchanges. The Meeting was concluded at 4:42 p.m. Till the time of conclusion, 78 Members attended the meeting. For Alembic Pharmaceuticals Limited Manisha Saraf Company Secretary ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123